---
schema_version: "secwatch.filing_event.v1"
accession: "0001640334-24-001769"
form_type: "8-K"
ticker: "BDPT"
cik: "0001575142"
company_name: "BIOADAPTIVES, INC."
filed_at: "2024-11-20T23:59:59+00:00"
generated_at: "2026-05-29T21:48:39.311181+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# BioAdaptives completes 1-for-300 reverse stock split effective Nov 21, 2024

## Summary
- Reverse split reduces outstanding shares from ~1.23B to ~4.1M.
- Split approved by shareholders on Sep 3, 2024; FINRA approved on Nov 20, 2024.
- Company cites need to exit sub-penny trading, attract institutional investors, and support new company-owned products.
- All new shares issued in book-entry form; fractional shares rounded based on decimal threshold.
- Intended to be tax-free for U.S. federal income tax purposes.

## SEC filing metadata
- accession: 0001640334-24-001769
- form_type: 8-K
- ticker: BDPT
- cik: 0001575142
- company_name: BIOADAPTIVES, INC.
- filed_at: 2024-11-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1575142/000164033424001769/0001640334-24-001769-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1575142/000164033424001769/bdpt_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001640334-24-001769
- JSON: https://secwatch.observer/filing/0001640334-24-001769.json
- Plain text: https://secwatch.observer/filing/0001640334-24-001769.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.